MiMedx Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
MiMedx Group, Inc. (MDXG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 24.48 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-02-25
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-12-31 was 15.00K shares, a 83.23% decline year-over-year.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-09-30 was 45.08K shares, a 58.83% decline year-over-year.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-06-30 was 88.90K shares.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-03-31 was 289.23K shares.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 24.48K shares, a 80.15% decline from fiscal 2024.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 123.33K shares, a 71.86% decline from fiscal 2023.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 438.21K shares, a 120.26% increase from fiscal 2022.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 198.95K shares, a 285.06% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 24.48K shares 10-K · filed 2026-02-25 | |||
| 2024-12-31 | 123.33K shares 10-K · filed 2025-02-26 | |||
| 2023-12-31 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 60.08K shares derived: sum of 2 quarters · filed 2024-02-28 | 148.98K shares derived: sum of 3 quarters · filed 2024-02-28 | 438.21K shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 45.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | 133.98K shares derived: sum of 2 quarters · filed 2023-10-30 | 423.21K shares 10-Q · filed 2023-10-30 | 512.66K shares derived: sum of 4 quarters · filed 2023-10-30 |
| 2023-06-30 | 88.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 378.13K shares 10-Q · filed 2023-08-01 | 467.58K shares derived: sum of 3 quarters · filed 2023-08-01 | 577.08K shares derived: sum of 4 quarters · filed 2023-08-01 |
| 2023-03-31 | 289.23K shares 10-Q · filed 2023-05-02 | 378.68K shares derived: sum of 2 quarters · filed 2023-05-02 | 488.18K shares derived: sum of 3 quarters · filed 2023-05-02 | 488.18K shares derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-12-31 | 89.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 198.95K shares derived: sum of 2 quarters · filed 2023-02-28 | 198.95K shares derived: sum of 3 quarters · filed 2023-02-28 | 198.95K shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 109.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 109.50K shares derived: sum of 2 quarters · filed 2022-11-02 | 109.50K shares 10-Q · filed 2022-11-02 | 161.17K shares derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 0.00 shares 10-Q · filed 2022-08-02 | 51.67K shares derived: sum of 3 quarters · filed 2022-08-02 | 51.67K shares derived: sum of 4 quarters · filed 2022-08-02 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-03 | 51.67K shares derived: sum of 2 quarters · filed 2022-05-03 | 51.67K shares derived: sum of 3 quarters · filed 2022-05-03 | 51.67K shares derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-12-31 | 51.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 51.67K shares derived: sum of 2 quarters · filed 2022-02-28 | 51.67K shares derived: sum of 3 quarters · filed 2022-02-28 | 51.67K shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 0.00 shares derived: sum of 2 quarters · filed 2021-11-02 | 0.00 shares 10-Q · filed 2021-11-02 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 0.00 shares 10-Q · filed 2021-08-03 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-04-28 | |||
| 2020-12-31 | 351.35K shares 10-K · filed 2021-03-08 | |||
| 2019-12-31 | 661.81K shares 10-K · filed 2020-07-06 | |||
| 2018-12-31 | 5.47M shares 10-K · filed 2020-03-17 | |||
| 2017-09-30 | 2.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | 12.66K shares derived: sum of 2 quarters · filed 2017-10-31 | 68.99K shares 10-Q · filed 2017-10-31 | 179.32K shares derived: sum of 4 quarters · filed 2017-10-31 |
| 2017-06-30 | 10.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | 66.83K shares 10-Q · filed 2017-07-31 | 177.15K shares derived: sum of 3 quarters · filed 2017-07-31 | 186.32K shares derived: sum of 4 quarters · filed 2017-07-31 |
| 2017-03-31 | 56.33K shares 10-Q · filed 2017-05-01 | 166.66K shares derived: sum of 2 quarters · filed 2017-05-01 | 175.82K shares derived: sum of 3 quarters · filed 2017-05-01 | 192.51K shares derived: sum of 4 quarters · filed 2017-05-01 |
| 2016-12-31 | 110.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 119.49K shares derived: sum of 2 quarters · filed 2017-03-01 | 136.19K shares derived: sum of 3 quarters · filed 2017-03-01 | 148.68K shares 10-K · filed 2017-03-01 |
| 2016-09-30 | 9.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | 25.86K shares derived: sum of 2 quarters · filed 2016-11-08 | 38.35K shares 10-Q · filed 2016-11-08 | 55.52K shares derived: sum of 4 quarters · filed 2017-02-22 |
| 2016-06-30 | 16.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | 29.19K shares 10-Q · filed 2016-08-02 | 46.35K shares derived: sum of 3 quarters · filed 2017-02-22 | 95.35K shares derived: sum of 4 quarters · filed 2017-02-22 |
| 2016-03-31 | 12.50K shares 10-Q · filed 2016-05-10 | 29.66K shares derived: sum of 2 quarters · filed 2017-02-22 | 78.66K shares derived: sum of 3 quarters · filed 2017-02-22 | |
| 2015-12-31 | 17.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | 66.16K shares derived: sum of 2 quarters · filed 2017-02-22 | 69.50K shares 10-K · filed 2017-02-22 | |
| 2015-09-30 | 49.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 52.33K shares 10-Q · filed 2015-11-06 | ||
| 2015-06-30 | 3.33K shares 10-Q · filed 2015-08-07 | |||
| 2014-12-31 | 84.33K shares 10-K · filed 2015-03-13 | |||
| 2013-12-31 | 35.50K shares 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |